Internal Medicine · Jersey City, NJ
NPI
1245217751
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3 Webster Ave
Jersey City, NJ, 07307
Phone (201) 798-2900
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
896 services
Medicare patients, 2024
59
Average age 68
Drug cost, 2024
$1.4M
1,148 prescriptions
Company payments, 2025
$17.67
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carl Restivo Jr. was code J9250 (methotrexate sodium, 5 mg), 228 times for 16 patients. In total Carl Restivo Jr. billed 896 services in 9 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9250 Methotrexate sodium, 5 mg | Office | 228 | 16 | $0.21 | $47.04 |
| 96401 Chemotherapy Administration | Office | 215 | 22 | $61.31 | $13K |
| J9260 Injection, methotrexate sodium, 50 mg | Office | 154 | 20 | $2.06 | $317 |
| 99213 Office E&M - Established | Office | 118 | 43 | $75.84 | $8,949 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 52 | 17 | $5.57 | $290 |
| 20605 Joint Injection | Office | 52 | 17 | $48.36 | $2,515 |
| 99204 Office E&M - New | Office | 14 | 14 | $129.03 | $1,806 |
By year: 2022 $36K for 1,896 services; 2023 $32K for 1,548 services; 2024 $28K for 896 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carl Restivo Jr. prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 286 prescriptions and refills. In total Carl Restivo Jr. wrote 1,148 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 286 | 313 | 55 | $7,383 |
| Diclofenac Sodium Generic | 166 | 168 | 74 | $3,462 |
| Humira(Cf) Adalimumab | 149 | 149 | 15 | $1.1M |
| Sulfasalazine Generic | 66 | 68 | 22 | $478 |
| Meloxicam Generic | 60 | 66 | 25 | $168 |
| Tramadol Hcl Generic | 54 | 54 | Under 11 | $344 |
| Prednisone Generic | 45 | 46 | Under 11 | $228 |
| Nabumetone Generic | 42 | 42 | 15 | $530 |
| Naproxen Generic | 36 | 36 | 23 | $465 |
| Alendronate Sodium Generic | 25 | 25 | Under 11 | $77.19 |
| Hadlima(Cf) Adalimumab-Bwwd | 16 | 16 | Under 11 | $16K |
| Leflunomide Generic | 15 | 15 | Under 11 | $590 |
| Amlodipine Besylate Generic | 13 | 25 | Under 11 | $132 |
| Kevzara Sarilumab | 12 | 12 | Under 11 | $49K |
| Cosentyx (2 Syringes) Secukinumab | 12 | 12 | Under 11 | $83K |
Brand drugs: 288 claims; generic drugs: 860 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carl Restivo Jr. $17.67 ($17.67 in general payments such as food, travel and fees) from 1 company. The largest payer was Genzyme Corporation with $17.67.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $17.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.